No abstract

Echinococcosis is endemic in various regions of Turkey. Cardiac involvement in echinococcosis is rare, and lone cardiac hydatid cysts are even more unusual. Because cardiac hydatid disease can be fatal, even asymptomatic patients are optimally referred for surgical treatment. We present a rare case of a lone, primary, mobile hydatid cyst in the left atrium of a 62-year-old woman. The cyst caused dyspnea from left ventricular inflow obstruction. In addition to reporting the patient's fatal case, we discuss cardiac hydatid cysts in terms of the scant medical literature.

trial septal defect is the third in frequency of congenital cardiac disorder in adults following bicuspid aortic valve and mitral valve prolapsed.1 Serious and large ASDs are repaired by open surgery at operating room, while ASDs with small and medium diameter are closed by occluder through percutaneous transvenous way under scopy in catheter room and with echocardiographic imaging. ASD closing by interventional cardiac catheterization is preferred in patients with suitable defect anatomy due to requirement of shorter hospital stay, its administration under sedation and lack of need for sternotomy and cardiopulmonary bypass (CPB). However percutaneous closing procedure has certain complications such as inappropriate placement of occluder, embolization and perforation which require emergency surgery. 2,3 In this report, we present a case of defect repair following embolization of septal occluder to arcus aorta and its surgical removal during closing intervention of an ASD of 28 mm. 51Emergency Care Intervention for Embolization of Atrial Septal Defect Device Implanted by Transcathater Method: Case Report A AB BS ST TR RA AC CT T Atrial septal defect (ASD) is a common congenital cardiac disorder in children, while it is the most frequently seen cardiac disorder in adults. During closure of ASD by an amplatzer septal occluder of 28 mm in a female patient aged 40 years old, embolization of ASD closure device was seen toward the left subclavian artery exit at arcus aorta. In this report, we present a successful emergency intervention following the embolization of ASD closure device to arcus aorta during percutaneous ASD closing procedure.K Ke ey yw wo or rd ds s: : Septal occluder device; atrial septal defect 2; heart defects, congenital Ö ÖZ ZE ET T Atriyal septal defekt(ASD) çocuklarda yaygın görülen bir doğuştan kalp hastalığı iken, yetişkinlerde görülen en sık doğuştan kalp hastalığıdır. Kırk yaşında kadın hastaya 28 mm amplatzer septal oklüder ile ASD kapama işlemi esnasında ASD kapama cihazının arkus aortada sol subklavian arter çıkışına embolize olduğu görüldü. Bu yazıda perkütan ASD kapatma işlemi esnasında ASD kapama cihazının arkus aortaya embolizasyonu sonrası gerçekleştirilen başarılı cerrahi tedavisi sunuldu.A An na ah ht ta ar r K Ke el li im me el

Objective: The aim of this study was to assess the effectiveness and safety of autologous bone marrow stem cell (ABMMNC) treatment in patients with thromboangiitis obliterans (TAO, Buerger's disease). Materials and methods:In this prospective study, twenty-two male patients with TAO were treated with ABMMNC implantation. All patients were Class II and III according to Rutherford Classification with a mean age of 48.27 ± 11.55 years. The mean follow up period was 30 ± 22.12 (range 9-64) months. Control visits were at weeks 4, 12 and 24. At each control visit, collateralization scores with digital substrat angiography (DSA) or computerised tomography (CT) angiography, treadmill maximum walking distance test, ankle brachial pressure index (ABPI) measurement and visual analogue scale (VAS) evaluation were performed. Results:The treadmill painless walking distance test was found 272.27 ± 164.96 meter (m) before implantation, and 310 ± 172.54 m, six months after the ABMMNC implantation (p=0.003*, p<0.008); the mean VAS scores before implantation, and after 6 months were 6.25 ± 1.50, and 5.01 ± 0.86. (p=0.003*, p<0.008). The mean ABPI (demonstrating the tissue perfusion) before and 6 months after implantation were 0.507 ± 0.06 and 0.66 ± 0.1 (p=0.003*, p<0.016). Six months after implantation, new collateral development was evaluated by angiography and collateralization scores were +3 in 8 patients, +2 in 4 patients, +1 in 8 patients and +0 in 2 patients. Conclusion:The findings of this study suggest that ABMMNC implantation in the treatment of patients with TAO might be safe and effective option for treating ischaemic limbs.